Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab

Conclusions The clinical course of carryover PML was mild in both patients, suggesting that B-cell depletion possibly did not aggravate PML-IRIS in these 2 patients.

http://nn.neurology.org/cgi/content/short/8/1/e904?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - October 13, 2020 Category: Neurology Authors: Toorop, A. A., van Lierop, Z. Y. G., Strijbis, E. E. M., Teunissen, C. E., Petzold, A., Wattjes, M. P., Barkhof, F., de Jong, B. A., van Kempen, Z. L. E., Killestein, J. Tags: Multiple sclerosis Article Source Type: research